Inventor · disambiguated record
Raymond Kaempfer
Also filed as: KAEMPFER RAYMOND
12 granted patents·1 pending application·31 citations·filing 1997–2020
87Inventor score
Files withYISSUM RES DEV CO6YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD5ATOX BIO LTD1KAEMPFER RAYMOND1
Top patents by PatentIndex Score
13 records- 0185US9546207B2Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereofYISSUM RES DEV CO·Filed 2013·Granted Jan 17, 2017·5 cites·3 claims
- 0279US9963497B2Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2014·Granted May 8, 2018·4 cites·22 claims
- 0377US8535672B2Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereofKAEMPFER RAYMOND·Filed 2004·Granted Sep 17, 2013·8 cites·21 claims
- 0475US7060277B2Broad spectrum antagonists and vaccines directed against pyrogenic exotoxinsYISSUM RES DEV CO·Filed 2002·Granted Jun 13, 2006·5 cites·12 claims
- 0572US10280209B2Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Granted May 7, 2019·1 cites·17 claims
- 0660US2006222650A1Broad spectrum pyrogenic antagonists and vaccines directed against pyrogenic exotoxinsYISSUM RES DEV CO·Filed 2006·Application pending·0 cites
- 0753US11304989B2Peptides for use in the treatment of viral infectionsYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Granted Apr 19, 2022·0 cites·8 claims
- 0850US11613565B2Isolated peptides derived from the B7 ligand dimer interface and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2020·Granted Mar 28, 2023·0 cites·5 claims
- 0949US7049133B2Regulation of gene expression through manipulation of mRNA splicing and its usesYISSUM RES DEV CO·Filed 2001·Granted May 23, 2006·1 cites·37 claims
- 1038US10584157B2Isolated peptides derived from the B7 ligand dimer interface and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2016·Granted Mar 10, 2020·0 cites·11 claims
- 1137US7189398B2Broad spectrum pyrogenic exotoxins antagonists and vaccinesYISSUM RES DEV CO·Filed 1998·Granted Mar 13, 2007·3 cites·48 claims
- 1230US9567367B2Synthetic peptides for treatment of bacterial infectionsATOX BIO LTD·Filed 2013·Granted Feb 14, 2017·0 cites·16 claims
- 1326US5837467AMethod for predicting the response to treatment with BCG of superficial bladder carcinomaYISSUM RES DEV CO·Filed 1997·Granted Nov 17, 1998·4 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Raymond Kaempfer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →